Cargando…

Prevalence of the Human Immunodeficiency Virus and associated factors in pregnant women in the state of Pará

OBJECTIVES: to analyze the prevalence of the Human Immunodeficiency Virus and the associated factors in pregnant women in the state of Pará. METHODS: retrospective, analytical, quantitative study with a sample of 332 medical records of HIV-positive pregnant women hospitalized at the Referral Materni...

Descripción completa

Detalles Bibliográficos
Autores principales: Pompeu, Helloyza Halana Fernanda Aquino, de Moraes, Lilia Pimenta, Santos, Camila Cristina Girard, Shibata, Helber Yanaguibashi, da Rocha, Jonas Elias Castro, Pereira, Alexandre Aguiar, Barros, Conceição do Socorro Damasceno, Monteiro, Cristiane Patrícia Siqueira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Enfermagem 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728863/
https://www.ncbi.nlm.nih.gov/pubmed/35766751
http://dx.doi.org/10.1590/0034-7167-2021-0171
Descripción
Sumario:OBJECTIVES: to analyze the prevalence of the Human Immunodeficiency Virus and the associated factors in pregnant women in the state of Pará. METHODS: retrospective, analytical, quantitative study with a sample of 332 medical records of HIV-positive pregnant women hospitalized at the Referral Maternity Hospital in the state of Pará between 2010 and 2019. Bivariate and multivariate statistical analysis were performed with the variables collected. RESULTS: the average prevalence in the period was 2.39% and the Metropolitan Region concentrated 66.87% of cases. There was a strong relationship between the number of antenatal consultations and lack of knowledge of serological status (p value equal to 0.01(E-17)) variables, and a correlation between the education and number of antenatal consultations variables. CONCLUSIONS: the increase in the infection rate during the study period revealed the need to intensify health actions, early diagnosis and strategies to improve adherence to antiretroviral treatment for maternal viral suppression and reduction of the risk of vertical transmission, contributing to improve public policies.